Ustekinumab Safety in Psoriasis, Psoriatic Arthritis, and Crohn's Disease: An Integrated Analysis of Phase II/III Clinical Development Programs

Journal article

Open access

Peer reviewed

DRUG SAFETY, v 42(6), pp 751-768

Jun 2019

PMID: 30739254

Files and links (1)

url

https://doi.org/10.1007/s40264-019-00797-3View

Published, Version of Record (VoR) Open

2 Record Views

87 citations in Scopus

Title: Ustekinumab Safety in Psoriasis, Psoriatic Arthritis, and Crohn's Disease: An Integrated Analysis of Phase II/III Clinical Development Programs
Publication Details: DRUG SAFETY, v 42(6), pp 751-768
Publisher: Springer Nature
Resource Type: Journal article
Language: English
Academic Unit: Drexel University
Web of Science ID: WOS:000468154200007
Scopus ID: 2-s2.0-85061339006
Other Identifier: 991021860714304721

This publication has contributed to the advancement of the following goals:

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types: Industry collaboration; Domestic collaboration; International collaboration
Web of Science research areas: Pharmacology & Pharmacy; Public, Environmental & Occupational Health; Toxicology